Clinical presentation of onychomycosis in hiv/aids: a review of 280 mexican cases.
作者信息
Moreno-Coutiño Gabriela, Arenas Roberto, Reyes-Terán Gustavo
机构信息
Clinical Dermatology,Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
出版信息
Indian J Dermatol. 2011 Jan;56(1):120-1. doi: 10.4103/0019-5154.77577.
Abstract
摘要
相似文献
1
Clinical presentation of onychomycosis in hiv/aids: a review of 280 mexican cases.
Indian J Dermatol. 2011 Jan;56(1):120-1. doi: 10.4103/0019-5154.77577.
2
Prevalence and etiology of onychomycosis in the HIV-infected Mexican population.
Eur J Dermatol. 2013 May-Jun;23(3):378-81. doi: 10.1684/ejd.2013.2015.
3
[Onychomycosis among children. A retrospective study of 233 Mexican cases].[儿童甲癣。对233例墨西哥病例的回顾性研究]
Gac Med Mex. 2008 Jan-Feb;144(1):7-10.
4
[Clinical and mycological evaluation of onychomycosis among Brazilian HIV/AIDS patients].
Rev Soc Bras Med Trop. 2011 Jan-Feb;44(1):40-2. doi: 10.1590/s0037-86822011000100010.
5
Virulence properties and sensitivity profile of Candida parapsilosis complex species and Kodamaea ohmeri isolates from onychomycosis of HIV/AIDS patients.白色念珠菌复合体种和 Kodamaea ohmeri 分离株的毒力特性和药敏谱与 HIV/AIDS 患者甲真菌病的关系。
Microb Pathog. 2019 Jul;132:282-292. doi: 10.1016/j.micpath.2019.05.012. Epub 2019 May 11.
6
Onychomycosis in HIV-positive patients.
Clin Podiatr Med Surg. 1998 Apr;15(2):305-15.
7
Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.墨西哥的输血相关艾滋病。临床谱、条件潜伏期分布及生存率
Rev Invest Clin. 1993 Mar-Apr;45(2):133-8.
8
The Mexican HIV/AIDS surveillance system: 1986-2001.墨西哥艾滋病毒/艾滋病监测系统：1986 - 2001年
AIDS. 2002 Dec;16 Suppl 3:S13-7. doi: 10.1097/00002030-200212003-00003.
9
A clinical and mycological study of onychomycosis in HIV infection.HIV感染患者甲癣的临床及真菌学研究
Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):397-401. doi: 10.4103/0378-6323.37057.
10
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.HIV 阳性个体甲癣的流行病学及患病率
Int J Dermatol. 2000 Oct;39(10):746-53. doi: 10.1046/j.1365-4362.2000.00012.x.
引用本文的文献
1
Retrospective Analysis of Onychomycosis Risk Factors Using the 2003-2014 National Inpatient Sample.利用2003 - 2014年全国住院患者样本对甲癣危险因素进行回顾性分析。
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024074. doi: 10.5826/dpc.1402a74.
2
Nail Changes in People Living with Human Immunodeficiency Virus: Observational and Cross-Sectional Study in a Third-Level Hospital.人类免疫缺陷病毒感染者的指甲变化：三级医院的观察性横断面研究
Skin Appendage Disord. 2022 Sep;8(5):368-375. doi: 10.1159/000524257. Epub 2022 Apr 22.
3
Subclinical Onychomycosis: Not Present in HIV-Positive Population?亚临床甲癣：在HIV阳性人群中不存在吗？
Skin Appendage Disord. 2019 Apr;5(3):155-157. doi: 10.1159/000494459. Epub 2018 Nov 21.
4
A preformulation strategy for the selection of penetration enhancers for a transungual formulation.一种用于选择经皮制剂渗透增强剂的预配方策略。
AAPS PharmSciTech. 2013 Jun;14(2):682-91. doi: 10.1208/s12249-013-9954-0. Epub 2013 Apr 10.
本文引用的文献
1
Cutaneous infections associated with HIV/AIDS.与艾滋病毒/艾滋病相关的皮肤感染。
Dermatol Clin. 2006 Oct;24(4):473-95, vi. doi: 10.1016/j.det.2006.06.010.
2
A new classification of onychomycosis.甲癣的一种新分类。
Br J Dermatol. 1998 Oct;139(4):567-71. doi: 10.1046/j.1365-2133.1998.02449.x.
3
Disorders of the nails and hair associated with human immunodeficiency virus infection.
Int J Dermatol. 1992 Jul;31(7):453-7. doi: 10.1111/j.1365-4362.1992.tb02688.x.
Zotero 插件